Stockscreener 앱 받기
48.31
1.63%
-0.80
시간 외 거래:
48.34
0.03
+0.06%
Boston Scientific Corp 주식(BSX)의 최신 뉴스
Boston Scientific Corp (NYSE:BSX): A Decent Value Play with Strong Fundamentals and an Attractive Valuation - ChartMill
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Unusual Options Activity Points to Boston Scientific Stock as a Hot M&A Target - Barchart.com
Boston Scientific Corp ($BSX) Q2 2025 Earnings Call Slushi Twist (3k72Vx1f7J) - Mshale
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MSN
Boston Scientific (BSX) Experiences Significant Options Activity on Thursday - GuruFocus
BSX Downgraded by Wolfe Research -- Rating Changed to Peer Perfo - GuruFocus
BSX vs. ABT: Which Medical Stock Has More Upside Potential? - TradingView
Wolfe Research cuts Boston Scientific rating as key growth drivers falter - Investing.com Nigeria
Wolfe Research downgrades Boston Scientific stock rating on growth concerns - Investing.com
Boston Scientific’s $1.5B bet signals heart valve market battle - Modern Healthcare
Why Boston Scientific Stock Was Sliding This Week - The Motley Fool
Barclays Remains a Buy on Boston Scientific (BSX) - The Globe and Mail
Our Boston Scientific Pick Has Suffered. We’re Pulling the Recommendation. - Barron's
Assessing Boston Scientific (BSX) Valuation After Strong SEISMIQ 4CE Trial Results - simplywall.st
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
BSX Maintained by Leerink Partners -- Price Target Lowered to $7 - GuruFocus
Press Release: Pablo José Hernández Rivera Visits Boston Scientific in Dorado to Highlight Potential of Medical Manufacturing in Puerto Rico - Quiver Quantitative
This Boston Scientific Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Thursday - Benzinga
Wells Fargo cuts Boston Scientific to ’Equal Weight’ on Watchman slowdown - Investing.com
RBC Capital reiterates Boston Scientific stock rating on Watchman outlook - Investing.com
BSX Stock: Don’t Try To Catch The Falling Knife - Trefis
Citigroup Adjusts Boston Scientific Price Target to $70 From $87, Maintains Buy Rating - marketscreener.com
Bernstein Adjusts Boston Scientific Price Target to $76 From $97, Maintains Outperform Rating - marketscreener.com
Leerink cuts Boston Scientific stock price target on Watchman outlook - Investing.com
Leerink Partners Adjusts PT on Boston Scientific to $74 From $87, Maintains Outperform Rating - marketscreener.com
Wells Fargo Downgrades Boston Scientific to Equalweight From Overweight, Adjusts PT to $55 From $75 - marketscreener.com
Goldman Sachs Adjusts Price Target on Boston Scientific to $71 From $81, Maintains Buy Rating - Moomoo
Barclays Adjusts Price Target on Boston Scientific to $89 From $96, Maintains Overweight Rating - marketscreener.com
Time To Buy The Dip In Boston Scientific Stock? - Trefis
Boston Scientific Stock Falls 12% In A Single Day, Time To Buy The Stock? - Trefis
Stock Market Today, May 27: Boston Scientific Plunges After Reiterating Underwhelming Full Year Growth Guidance - The Motley Fool
Boston Scientific Corp (BSX) Stock Down 12.5% -- Now Undervalued? GF Score: 83/100 - GuruFocus
Boston Scientific (BSX) Device Succeeds in Over 93% of Patients in Its Pivotal Trial - Insider Monkey
Watchman Woes: Boston Scientific Shares Plunge on Weak Demand - Medical Device and Diagnostic industry
Boston Scientific Is the Worst Performing S&P 500 Stock. Here’s Why. - Barron's
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Boston Scientific Is Betting $1.5 Billion on a Massive Market -- and Wall Street Is Paying Attention - The Motley Fool
Boston Scientific Is Betting $1.5 Billion on a Massive Market -- and Wall Street Is Paying Attention - The Motley Fool
Boston Scientific Corp Stock (BSX) Moved Down by 12.33% on May 27: What Investors Need To Know - tradingkey.com
Boston Scientific (BSX) Plunges 10.3% to $51.69 - AlphaStreet
Why Did BSX Cut FY26 Guidance? CEO Details Three Unanticipated Factors At Bernstein Conference - Yahoo Finance
Boston Scientific hits two-year low after flagging weaker demand for heart device - Reuters
Boston Scientific shares fall 10% on Watchman weakness, competitive pressures - Investing.com
Boston Scientific slides after flagging slowdown in Watchman heart device usage - marketscreener.com
Boston Scientific slides after flagging slowdown in Watchmen heart device usage - Yahoo Finance
Boston Scientific (BSX) Shares Drop 10% Amid Demand Slowdown for WATCHMAN Implant - GuruFocus
Stifel Adjusts Price Target on Boston Scientific to $75 From $85, Maintains Buy Rating - marketscreener.com
Boston Scientific (BSX) slides after management cuts 2026 growth outlook - Quiver Quantitative
Boston Scientific (BSX) Plunges 10% Following Bernstein Conference Guidance Revision - Blockonomi
Here’s Why Boston Scientific Stock (BSX) Is Crashing Today - TipRanks
Boston Scientific hits 52-week low on Watchman headwinds - Seeking Alpha
Why is Boston Scientific stock plunging today? - Investing.com
Why is Boston Scientific stock plunging today? By Investing.com - Investing.com Canada
Boston Scientific Down Over 10%, On Track for Lowest Close Since November 2023 -- Data Talk - Moomoo
Cramer’s Stop Trading: Boston Scientific - CNBC
Boston Scientific stock hits 52-week low at $52.29 By Investing.com - Investing.com Nigeria
Boston Scientific stock hits 52-week low at $52.29 - Investing.com
Boston Scientific stock tumbles 6% after guidance cut By Investing.com - Investing.com Australia
0.59%
2.33%
자본화:
|
볼륨(24시간):